Penumbra, Inc. (PEN) Stock

Healthcare · Medical Devices · Member of Other US Stocks

Penumbra, Inc. (PEN) closed at USD 320.12 on 2026-10-14, a change of +35.9 % over the past year, with a market capitalization of USD 12.65B.

Penumbra, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Penumbra, Inc. key figures

Previous close

USD 320.12 (2026-10-14)

1-year change

+35.9 %

Market cap

USD 12.65B

Enterprise value

USD 12.21B

P/E ratio (trailing)

78.92

P/E ratio (forward)

52.38

EPS (trailing)

4.07

EPS (forward)

6.13

PEG ratio

3.61

Price to book

8.27

Revenue growth

14.9 %

Earnings growth

-23.5 %

Dividend per share (trailing)

0.00

Short ratio

6.03

Employees

4,700

Analyst consensus (third-party)

hold

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Penumbra, Inc.

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, Access25; MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, aspiration pump, and other components and accessories under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that include the Penumbra Coil 400, for the treatment of aneurysms and other complex lesions, detachable coils of neurovascular lesions under the Penumbra SMART COIL, SwiftSET, and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands. In addition, it provides peripheral embolization products, such as Ruby Embolization Platform, which consists of detachable coils for peripheral applications; Ruby LP and XL Embolization Platform; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; Packing Coil LP; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers neurosurgical tools comprising the Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. It sells its products through direct sales organizations and distributors. The company was incorporated in 2004 and is based in Alameda, California.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Penumbra, Inc. and compare it with other stocks.